Gastroesophageal Reflux Disease (GERD)
7 competing products in clinical development for Gastroesophageal Reflux Disease (GERD).
Pipeline by Phase
Phase 11
Phase 36
All Products (7)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Rabeprazole ER + Ranitidine | Eisai | Phase 3 | Completed | 40 |
| Rabeprazole sodium + Esomeprazole | Eisai | Phase 3 | Completed | 40 |
| Rabeprazole ER + Ranitidine | Eisai | Phase 3 | Completed | 40 |
| rabeprazole + rabeprazole | Eisai | Phase 3 | Completed | 40 |
| Rabeprazole sodium + Esomeprazole | Eisai | Phase 3 | Completed | 40 |
| Rabeprazole sodium + Esomeprazole | Eisai | Phase 3 | Completed | 40 |
| Rabeprazole sodium 5 mg + Rabeprazole sodium 10 mg | Eisai | Phase 1 | Completed | 29 |